19th ICASA | 4 - 9 DEC 2017 | ABIDJAN | CÔTE D'IVOIRE
INTERNATIONAL CONFERENCE ON AIDS AND STIs IN AFRICA
ICASA 2017 Côte d'Ivoire > Track Description > Track A: Basic Science (Biology & Pathogenesis)
Go Back

Track A: Basic Science (Biology & Pathogenesis)

Source:

Description: This track will encompass all aspects of fundamental HIV biology and the host response to HIV. Areas of focus will include HIV infection and replication, transmission, genetics, evolution, structure and function, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, interaction of micronutrients, co -infection and progress in animal models. Pre-clinical vaccine, microbicide, and drug development will be important themes of this track.

Abstract Categories
HIV evolution, viral diversity and bioinformatics

A1. HIV-1/2: Origins, evolution, diversity and response to ARV
A2. Molecular epidemiology of HIV diversity
A3. Bioinformatics analysis of HIV diversity and drug resistance

Immunology of HIV

A4. Innate immune responses and function in natural history of HIV infection
A5. Humoral immune responses and function in natural history of HIV infection
A6. Cellular immune responses and function in natural history of HIV infection
A7. Immune responses in resistant cohorts: elite controllers and exposed uninfected

Transmission and Pathogenesis (HIV-1/2)

A8. Viral determinants of HIV pathogenesis
A9. Acute and early HIV infection
A10. Animal models of transmission, disease resistance and progression
A11. HIV transmission (mucosal and mother to child transmission; other transmission)
A 12 Ageing and HIV

Host genetics and HIV infections

A13. Host genetics of resistance and susceptibility and restriction factors

HIV: Co-infections and emerging pathogens

A14. HIV super-infection
A15. HIV co-infection with TB and other pathogens (Hepatitis B, C, HPV,….)
A16. HIV interactions with emerging and other opportunistic pathogens

HIV: Drug development and resistance

A17. HIV drug development: Synthetic, traditional and microbicides
A18. Molecular mechanisms of drug action and antiviral drug resistance and drug interaction
A19. Nucleic acid based HIV and SIV therapies
A20. Targeting and HIV persistence during ART (cure strategies)

Vaccine development

A21. Clinical trials in HIV vaccine development
A22. Animal models for vaccine development

Interaction of micronutrients and HIV infection

A23. Effect of micronutrients in HIV and AIDS pathogenesis, transmission and treatment
A24. Mechanisms of micronutrient and HIV interactions

Diagnostics tools development (for use in resource limited settings)

A25. Novel assays of immune responses in HIV and AIDS
A26. Novel assays and cost effectiveness tools for virological monitoring
A27. Rapid and cost-effective HIV screening and diagnostic methods
A28. HIV drug resistance testing

Characterization of HIV latency and viral reservoirs

A29 Measurement of HIV/SIV reservoirs
A30 Host cellular latency
A31. Targeting and eradication of reservoirs


Leave a Comment or Questions

Time limit is exhausted. Please reload CAPTCHA.

ONGOING
ACCOMMODATION
SECURE YOUR VISA
OFFICIAL CARRIER OF ICASA 2017
MEMORY OF ICASA 2015